← Scroll for more →
Financial Statements — ALMR
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Cash & Equivalents | 132.97 | 64.59 |
| Short-term Investments | 117.08 | 0.00 |
| Accounts Receivable | 20.34 | 19.52 |
| Inventory | 45.41 | 39.93 |
| Total Current Assets | 331.38 | 141.47 |
| Property, Plant & Equipment | 13.36 | 10.47 |
| Total Non-current Assets* | 59.59 | 44.98 |
| Total Assets | 390.98 | 186.45 |
| Accounts Payable | 13.79 | 5.64 |
| Total Current Liabilities | 27.96 | 24.05 |
| Total Non-current Liabilities* | 50.16 | 105.48 |
| Total Liabilities | 78.12 | 129.53 |
| Retained Earnings | (203.30) | (190.10) |
| Total Stockholder Equity | 312.86 | (178.07) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Revenue | 29.43 | 26.04 |
| Cost of Revenue | 11.71 | 11.58 |
| Gross Profit | 17.72 | 14.46 |
| Research & Development | 13.82 | 13.02 |
| Selling, General & Admin | 17.43 | 13.79 |
| Total Operating Expenses | 31.25 | 26.80 |
| Operating Income | (13.53) | (12.35) |
| Pretax Income | (13.29) | (20.86) |
| Tax Provision | (0.09) | 0.46 |
| Net Income | (13.20) | (21.32) |
| Basic EPS | (0.22) | (1.74) |
| Diluted EPS | (0.22) | (1.74) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | (11.32) | (20.35) |
| Capital Expenditures | 3.64 | 0.60 |
| Free Cash Flow* | (14.96) | (20.95) |
| Investing Cash Flow | (120.80) | (0.78) |
| Financing Cash Flow | 201.84 | 55.76 |
← Scroll for more columns →
* Derived from reported values